|
PLK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70790073592298E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82180000002563E-06 |
| Normal-vs-Stage2 |
1.305850E-02 |
| Normal-vs-Stage3 |
4.8996000000523E-06 |
| Normal-vs-Stage4 |
2.152300E-02 |
| Stage1-vs-Stage2 |
3.412000E-01 |
| Stage1-vs-Stage3 |
2.158400E-03 |
| Stage1-vs-Stage4 |
1.931790E-01 |
| Stage2-vs-Stage3 |
1.240630E-01 |
| Stage2-vs-Stage4 |
8.359200E-01 |
| Stage3-vs-Stage4 |
2.780800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26489996254975E-09 |
| Normal-vs-AfricanAmerican |
2.28929999999128E-05 |
| Normal-vs-Asian |
5.122200E-02 |
| Caucasian-vs-AfricanAmerican |
7.921600E-01 |
| Caucasian-vs-Asian |
3.178800E-01 |
| AfricanAmerican-vs-Asian |
2.247400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.75080000392103E-08 |
| Normal-vs-Female |
4.95009999657015E-09 |
| Male-vs-Female |
4.455500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.41399999999503E-05 |
| Normal-vs-Extreme_Weight |
8.33010000000911E-05 |
| Normal-vs-Obese |
5.41879999982342E-07 |
| Normal-vs-Extreme_Obese |
1.400210E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.165600E-02 |
| Normal_Weight-vs-Obese |
5.612800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.126000E-02 |
| Extreme_Weight-vs-Obese |
1.167860E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.748600E-01 |
| Obese-vs-Extreme_Obese |
8.396600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.479100E-03 |
| Normal-vs-Age(41-60Yrs) |
9.63019664013132E-11 |
| Normal-vs-Age(61-80Yrs) |
1.51832999999435E-05 |
| Normal-vs-Age(81-100Yrs) |
5.894000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.305030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.808000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.608000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.188410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.910200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.210200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.95989999954394E-07 |
| Normal-VS-Type2 PRCC |
1.92861999999128E-05 |
| Normal-VS-KIRP CIMP |
7.080400E-03 |
| Normal-VS-Unclassified PRCC |
4.87920000002973E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.005400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.330200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.524500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.178500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.339180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.694200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.164900E-04 |
| Normal-vs-N1 |
1.5379900000001E-05 |
| Normal-vs-N2 |
1.695770E-01 |
| N0-vs-N1 |
1.298040E-03 |
| N0-vs-N2 |
6.625800E-01 |
| N1-vs-N2 |
2.257600E-01 |
|
|
